Cholinesterase inhibitors for behavioral disturbance in dementia.
The authors review the literature from the last year examining the benefits of cholinesterase inhibitors in the treatment of behavioral disturbance in Alzheimer's disease (AD) and other dementias. Previous review has indicated that cholinesterase inhibitors have psychotropic properties. We found more evidence to support both the benefits of cholinesterase inhibitors in behavioral disturbance, and that specific behaviors may be selectively responsive to treatment.
Daly
E J
EJ
Department of Psychiatry, Massachusetts General Hospital, MGH East (149-9124), 149 13th Street, Charlestown, MA 02129, USA. daly@psych.mgh.harvard.edu
Falk
W E
WE
Brown
P
P
D000368:Aged; D000369:Aged, 80 and over; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000145:classification / Q000523:psychology*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology*
D002800:Cholinesterase Inhibitors